Anil Koul

Anil Koul (born 1 June 1972) is a scientist and former Director of India's CSIR-Institute of Microbial Technology (IMTECH). He is also the vice president and Head of Global Public Health discovery at Johnson & Johnson. He is member of Board of Directors of Janssen Pharmaceutica NV, the European subsidiary of J&J. He is also a professor of Translational Discovery at London School of Hygiene and Tropical Medicine (LSHTM).

His major scientific career achievement is his key role in the discovery and development of a new tuberculosis drug, bedaquiline, the first drug approved in 45 years for treatment of drug-resistant tuberculosis. Koul has been awarded a number of awards for his contribution to discovery of Bedaquiline. Provided by Wikipedia
Showing 1 - 2 results of 2 for search 'Anil Koul', query time: 0.01s Refine Results
  1. 1
    An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates

    An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates by Jody Phelan, Klaas Van den Heede, Serge Masyn, Rudi Verbeeck, Taane G. Clark, Dirk A. Lamprecht, Anil Koul, Richard J. Wall

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Author Correction: An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates

    Author Correction: An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates by Jody Phelan, Klaas Van den Heede, Serge Masyn, Rudi Verbeeck, Taane G. Clark, Dirk A. Lamprecht, Anil Koul, Richard J. Wall

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: